Lataa...
IMMU-32. RETARGETING IMMUNOEDITED GLIOMA ESCAPE VARIANTS WITH ADOPTIVE CELLULAR THERAPY
INTRODUCTION: Adoptive T cell immunotherapy (ACT) leads to extension of median survival and long-term cures of treatment-resistant models of malignant glioma, medulloblastoma, and pontine gliomas. While very promising, tailored strategies to overcome ACT failure are needed. Therefore, we studied the...
Tallennettuna:
| Julkaisussa: | Neuro Oncol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216297/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.535 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|